Share Repurchase Programme - 2024

Helios Underwriting Plc
09 July 2024
 

 

9th July 2024

Helios Underwriting plc

("Helios" or the "Company")

Share Repurchase Programme - 2024

Further to the share repurchase announcement released by the Company on 19 June 2024, the Company will continue with this Programme under the renewed General Authority obtained at the 2024 AGM on 28 June 2024 under the below parameters.

About the Programme

·     The aggregate number of ordinary shares of 10 pence each ("Ordinary Shares") acquired by the Company pursuant to this share purchase programmes shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the authority obtained at the Company's AGM to repurchase up to a maximum 7,474,514 Ordinary Shares ("General Authority") that was approved at the 2024 AGM on 28 June 2024.

·    In accordance with the General Authority, the maximum price paid per Ordinary Share acquired by the Company pursuant to the Programme is to be no more than:

105% of the average middle market closing price of an Ordinary Share on AIM for the five business days preceding the date of purchase; and

the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out

·    The Programme will commence on the date of this announcement and will continue until the earlier of either the expiration of the General Authority or until the maximum pecuniary amount has been purchased under the Programme.

·     The purchased Ordinary Shares will be held by the Company in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

·   Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The maximum price paid per Ordinary Share will be no more than the net tangible asset value of the Company.

·      The Company confirms that it currently has no unpublished inside information.

·     The Programme will operate in accordance with and under the terms of the relevant General Authority, and within the regulatory limit on the quantity of Ordinary Shares the Company may purchase on a single day. The Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made pursuant to it.

·   However, there will be circumstance where the Company conducts share repurchases such that they exceed 25 per cent of the average daily volume in Ordinary Shares for the 20 trading days prior to the share repurchase.

·     As at 9th July 2024 the Company's total issued share capital consisted of 77,945,833 Ordinary Shares, with one voting right per share. The Company holds 3,200,689 Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company was 74,745,144. 

For further information, please contact:

Helios Underwriting plc

Michael Wade - Chairman

Arthur Manners - Chief Financial Officer 
+44 (0)203 965 6441    


Deutsche Numis (Nomad and Broker)                                      

 Giles Rolls / Charles Farquhar                                    

+44 (0)20 7260 1000

 

FTI Consulting

 Ed Berry / Tom O'Brien

+44 (0)7703 330 199 / +44 (0)7929 021 492

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £512m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings